A Tale of Tacrolimus скачать в хорошем качестве

A Tale of Tacrolimus

Works Cited: The Evolution of Tacrolimus (FK506) I. The Landmark "Day Zero" & Early Clinical Experience FK 506 for liver, kidney, and pancreas transplantation The Lancet | Starzl TE, Todo S, Fung J, et al. Significance: The seminal paper detailing the first human use (March 1989) and the establishment of the "rescue phenomenon." The Story of FK 506 Begins with Thomas E. Starzl Editorial | Yilmaz Significance: An editorial recounting the historical narrative of Starzl’s involvement and the "pilgrimage" to Japan. Tacrolimus in liver transplantation PubMed Significance: Early review and data analysis establishing the drug as a standard in hepatic grafting. II. The "Architecture of Evidence": Randomized Trials & Outcomes The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation Fung JJ, et al. | Journal of Clinical Oncology Significance: The pivotal study proving tacrolimus superiority (freedom from rejection) over cyclosporine. Randomised trialomania? The multicentre liver transplant trials of tacrolimus PubMed / PMC Significance: A critical analysis of the early multicenter trials, addressing dosing controversies and the surgical "learning curve." What Have We Learned About Primary Liver Transplantation Under Tacrolimus Immunosuppression? Long-Term Follow-up of the First 1000 Patients Annals of Surgery | Jain A, Fung JJ, Starzl TE Significance: A landmark long-term follow-up study defining the "chronic" era of tacrolimus use. Primary Adult Liver Transplantation Under Tacrolimus: More Than 90 Months Actual Follow-Up Survival and Adverse Events Jain A, et al. Significance: Longitudinal data establishing the durability of tacrolimus-based grafts. Tacrolimus and transplantation: A decade in review Scott LJ, et al. Significance: A comprehensive retrospective looking at the first ten years of the drug's global impact. III. Expanding the Boundaries: Intestine & Multivisceral Clinical Intestinal Transplantation: A Decade of Experience at a Single Center Abu-Elmagd K, et al. Significance: Documents the Pittsburgh experience in making the "forbidden" organ (intestine) transplantable. Clinical intestinal transplantation in 1998: Pittsburgh experience Abu-Elmagd K Significance: Specific outcomes data on "grape cluster" and isolated intestinal grafts. Clinical Intestinal Transplantation: New Perspectives and Immunologic Considerations PMC Significance: Discusses the immunological basis for intestinal grafting and GVHD prevention. The Many Faces of Multivisceral Transplantation Starzl TE, et al. Significance: Foundational paper on the feasibility of multivisceral grafts. IV. Discovery, Mechanism & Pharmacology Draft Genome of Streptomyces tsukubaensis NRRL 18488, the Producer of Tacrolimus (FK506) ResearchGate Significance: The genetic characterization of the soil bacterium found near Mount Tsukuba. Streptomyces tsukubensis VKM Aс-2618D—an Effective Producer of Tacrolimus PMC Significance: Research on the production and biology of the producing strain. Renal Deletion of 12 kDa FK506-Binding Protein Attenuates Tacrolimus-Induced Hypertension PMC Significance: Mechanistic study exploring the side-effect profile (nephrotoxicity/hypertension) via the FKBP-12 pathway. Production of tacrolimus using coconut oil as an alternative to glucose Redalyc Significance: Industrial and biosynthetic optimization of the drug. V. Regulatory & Historical Context Tacrolimus (FK506) and the Pharmaceutical/Academic/Regulatory Triangle PMC Significance: Explains Starzl’s strategy of collaboration between Fujisawa, Pittsburgh, and the FDA. FDA Expands Indication for PROGRAF for Prevention of Organ Rejection in Lung Transplant Recipients Astellas Press Release Significance: The 2021 approval marking the evolution of the drug into lung transplantation. Astellas Receives FDA Approval for Use of Prograf (Tacrolimus) in Conjunction With Mycophenolate Mofetil Fierce Biotech Significance: Marks the shift to the modern "standard of care" combination therapy. Thomas E. Starzl: Transplantation pioneer PMC Significance: Biographical context on the surgeon who championed the drug against initial skepticism.